Recent imaging advances in neurology. (Q30916063)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808503 AND SRC:MED&resulttype=core&format=json

3 March 2020

title

Recent imaging advances in neurology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808503 AND SRC:MED&resulttype=core&format=json

3 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808503 AND SRC:MED&resulttype=core&format=json

3 March 2020

2

Flavia Niccolini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808503 AND SRC:MED&resulttype=core&format=json

3 March 2020

3

Marios Politis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808503 AND SRC:MED&resulttype=core&format=json

3 March 2020

publication date

26 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808503 AND SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808503 AND SRC:MED&resulttype=core&format=json

3 March 2020

volume

262

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808503 AND SRC:MED&resulttype=core&format=json

3 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808503 AND SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

2182-2194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808503 AND SRC:MED&resulttype=core&format=json

Positron emission tomography imaging in neurological disorders

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-( )-dihydrotetrabenzazine PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Diffusion tensor imaging and correlations to Parkinson rating scales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Transcranial sonography in movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease: comparison with DAT PET scans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

A new assessment tool for Parkinson disease: the nigral lesion load obtained by transcranial sonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Parkinson's disease cognitive network correlates with caudate dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Imaging of microglia in patients with neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Decreased microglial activation in MS patients treated with glatiramer acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Neuroimaging characteristics of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Cortical thinning is associated with disease stages and dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Initial cognitive decline is associated with cortical thinning in early Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Predicting dementia development in Parkinson's disease using Bayesian network classifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Diffusion tensor imaging reveals white matter changes associated with cognitive status in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Gait speed in Parkinson disease correlates with cholinergic degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Imaging: What can it tell us about parkinsonian gait?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Freezing of gait in Parkinson's disease is associated with functional decoupling between the cognitive control network and the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

The acute brain response to levodopa heralds dyskinesias in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Serotonergic mediated body mass index changes in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Potential of a new MRI for visualizing cerebellar involvement in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Cerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson's disease and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Neuromelanin magnetic resonance imaging in Parkinson's disease and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Neuroimaging in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

MRI measures of corpus callosum iron and myelin in early Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Functional and connectivity changes during working memory in Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Metabolic network as a progression biomarker of premanifest Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

A review of β-amyloid neuroimaging in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Frontotemporal dementia and related disorders: deciphering the enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Resting state functional connectivity in preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Hippocampal Hyperactivation Associated with Cortical Thinning in Alzheimer's Disease Signature Regions in Non-Demented Elderly Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Neuroimaging of epilepsy: lesions, networks, oscillations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Resting state networks in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Resting-state fMRI study of treatment-naïve temporal lobe epilepsy patients with depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Serotonin 1A receptors, depression, and memory in temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

α-[11C]-Methyl-L-tryptophan--PET in 191 patients with tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Can diffusion tensor imaging (DTI) identify epileptogenic tubers in tuberous sclerosis complex? Correlation with α-[11C]methyl-L-tryptophan ([11C] AMT) positron emission tomography (PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Perfusion Imaging of Focal Cortical Dysplasia Using Arterial Spin Labeling: Correlation With Histopathological Vascular Density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Traumatic brain injury: problems and opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Traumatic brain injury: PET imaging detects amyloid deposits after TBI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Detection of brain amyloid β deposition in patients with neuropsychological impairment after traumatic brain injury: PET evaluation using Pittsburgh Compound-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Inflammation after trauma: microglial activation and traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Decreased resting functional connectivity after traumatic brain injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

A prospective study of gray matter abnormalities in mild traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Neuroimaging after mild traumatic brain injury: review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Diffusion tensor imaging for outcome prediction in mild traumatic brain injury: a TRACK-TBI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Acute mild traumatic brain injury is not associated with white matter change on diffusion tensor imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Characterizing brain structures and remodeling after TBI based on information content, diffusion entropy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Default mode network functional and structural connectivity after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Damage to the Salience Network and interactions with the Default Mode Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Increased PK11195 PET binding in the cortex of patients with MS correlates with disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Translocator protein PET imaging for glial activation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Positron emission tomography imaging in multiple sclerosis-current status and future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Investigating the effect of exchange and multicomponent T(1) relaxation on the short repetition time spoiled steady-state signal and the DESPOT1 T(1) quantification method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Investigating exchange and multicomponent relaxation in fully-balanced steady-state free precession imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Diffusion tensor magnetic resonance imaging in patients with multiple sclerosis and its relationship with disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Brain proton magnetic resonance spectroscopy: introduction and overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

1H magnetic resonance spectroscopy in multiple sclerosis and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7711-X

Alteration of default mode network in high school football athletes due to repetitive subconcussive mild traumatic brain injury: a resting-state functional magnetic resonance imaging study

21 January 2018

1 reference

12 December 2020

Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome

1 reference

12 December 2020

Dopamine receptor mapping with PET imaging in Parkinson's disease

1 reference

12 December 2020

Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease

1 reference

12 December 2020

Exploring variations in functional connectivity of the resting state default mode network in mild traumatic brain injury

1 reference

12 December 2020

Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study

1 reference

12 December 2020

Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.

1 reference

12 December 2020

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.

1 reference

12 December 2020

Neuroimaging in Parkinson disease: from research setting to clinical practice

1 reference

12 December 2020

Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging

1 reference

12 December 2020

Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients

1 reference

12 December 2020

Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally

1 reference

12 December 2020

Current and new directions in MRI in multiple sclerosis

1 reference

12 December 2020

Positron emission tomography neuroimaging in Parkinson's disease

1 reference

12 December 2020

The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging study.

1 reference

12 December 2020

Resting State Functional Connectivity in Mild Traumatic Brain Injury at the Acute Stage: Independent Component and Seed-Based Analyses

1 reference

12 December 2020

Imaging biomarkers associated with cognitive decline: a review

1 reference

12 December 2020

Combining ESI, ASL and PET for quantitative assessment of drug-resistant focal epilepsy.

1 reference

12 December 2020

DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications.

1 reference

12 December 2020

Dyskinesias in Parkinson's disease: views from positron emission tomography studies

1 reference

12 December 2020

Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease.

1 reference

12 December 2020

Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal.

1 reference

12 December 2020

Amyloid deposition in early onset versus late onset Alzheimer's disease.

1 reference

12 December 2020

Abnormal synchrony of resting state networks in premanifest and symptomatic Huntington disease: the IMAGE-HD study.

1 reference

12 December 2020